Cannapharmarx (CPMD) has released an update.
CannaPharmaRx, an emerging power in the cannabis production industry, has successfully completed its initial series of cannabis harvests with products soon to be distributed across Canada and internationally, following independent lab testing. With an anticipated annual production capacity of 6000kg, translating to approximately $18 million in revenue, the company has secured pre-sale agreements for the bulk of its product. Additionally, CannaPharmaRx has scheduled an investor conference call to discuss year-to-date progress and future strategies.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.
